Paul A. Bunn, Jr, MD, Erin Schenk, MD, PhD, Jose Pacheco, MD, and Anastasios Dimou, MD
In this article, we review the new developments in neoadjuvant therapy for lung cancer.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: UBM Medica, a divsion of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
Paul A. Bunn, Jr, MD, Erin Schenk, MD, PhD, Jose Pacheco, MD, and Anastasios Dimou, MD
Kevin H. Hall, PharmD, BCOP
